Optimizing Neuronal Calcium Flux Analysis: A Python Framework for Alzheimer's and TBI Studies by Huiying Huang (490768)

“…Dead cells are identified via watershed algorithms, and all cells are segmented using Cellpose, an AI-based tool. …”

Table 10_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.xlsx by Peng Zhu (277243)

“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”

Image 2_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.tif by Peng Zhu (277243)

“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”

Table 5_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.xlsx by Peng Zhu (277243)

“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”

Image 3_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.tif by Peng Zhu (277243)

“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”

Image1_Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients.TIF by Zewei Chen (2936157)

“…Background<p>Melanoma, a malignant tumor of the skin, presents challenges in its treatment process involving modalities such as surgery, chemotherapy, and targeted therapy. …”

Table 2_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.xlsx by Peng Zhu (277243)

“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”

Image 1_Validation of the Somnolyzer 24×7 automatic scoring system in children with suspected obstructive sleep apnea.tif by Ignacio Boira (21562568)

“…Introduction<p>Manual scoring of polysomnography data is a laborious and complex process. Automatic scoring by current computer algorithms shows high agreement with manual scoring. …”

Table 1_Validation of the Somnolyzer 24×7 automatic scoring system in children with suspected obstructive sleep apnea.docx by Ignacio Boira (21562568)

“…Introduction<p>Manual scoring of polysomnography data is a laborious and complex process. Automatic scoring by current computer algorithms shows high agreement with manual scoring. …”

Table 6_Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma.xlsx by Peng Zhu (277243)

“…Utilizing scRNA-seq and bulk RNA-seq data, we performed a comprehensive differential expression analysis to highlight MitRGs. …”

Presentation1_Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model.pdf by Qingliu He (12528332)

“…The immune microenvironment of the risk model was quantified using a variety of immunological algorithms, which also identified its characteristics with regard to immunotherapy, immune response, and immune infiltration.…”

Image 6_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Table 1_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.xlsx by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Image 4_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Image 7_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Image 9_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Image 2_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Image 10_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Image 1_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”

Image 3_Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.tif by Wuyuan Liao (21776432)

“…</p>Methods<p>We systematically collected and analyzed genomic and clinical data from patients receiving anti-PD-1/PD-L1 immunotherapy across multiple cohorts. …”